141 related articles for article (PubMed ID: 19534622)
21. Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.
Schulten HJ; Al-Maghrabi J; Al-Ghamdi K; Salama S; Al-Muhayawi S; Chaudhary A; Hamour O; Abuzenadah A; Gari M; Al-Qahtani M
Anticancer Res; 2011 Dec; 31(12):4179-83. PubMed ID: 22199277
[TBL] [Abstract][Full Text] [Related]
22. Detection of BRAF V600E mutation in thyroid fine-needle aspiration specimens by High Resolution Melting (HRM) analysis.
Nechifor-Boilă A; Decaussin-Petrucci M; Gazzo S; Paşcanu I; Borda A
Rom J Morphol Embryol; 2012; 53(2):263-7. PubMed ID: 22732794
[TBL] [Abstract][Full Text] [Related]
23. BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma.
Rossi ED; Martini M; Capodimonti S; Lombardi CP; Pontecorvi A; Vellone VG; Zannoni GF; Larocca LM; Fadda G
Cancer Cytopathol; 2013 Jun; 121(6):291-7. PubMed ID: 23192956
[TBL] [Abstract][Full Text] [Related]
24. Difficulties of Preoperative Diagnosis of Cribriform Morular Thyroid Carcinoma.
Pan LH; Hang JF; Chen JY; Lee PS; Yeh YK; Huang TJ; Hwu CM; Kuo CS
Case Rep Endocrinol; 2024; 2024():6517236. PubMed ID: 38835742
[TBL] [Abstract][Full Text] [Related]
25. Clonal characterization of sporadic cribriform-morular variant of papillary thyroid carcinoma by laser microdissection-based APC mutation analysis.
Subramaniam MM; Putti TC; Anuar D; Chong PY; Shah N; Salto-Tellez M; Soong R
Am J Clin Pathol; 2007 Dec; 128(6):994-1001. PubMed ID: 18024325
[TBL] [Abstract][Full Text] [Related]
26. Cytological and molecular features of papillary thyroid carcinoma with prominent hobnail features: a case report.
Bellevicine C; Cozzolino I; Malapelle U; Zeppa P; Troncone G
Acta Cytol; 2012; 56(5):560-4. PubMed ID: 23075900
[TBL] [Abstract][Full Text] [Related]
27. Cytomorphologic and molecular features of hobnail variant of papillary thyroid carcinoma: case series and literature review.
Asioli S; Maletta F; Pagni F; Pacchioni D; Vanzati A; Mariani S; Palestini N; Lloyd RV; Sapino A
Diagn Cytopathol; 2014 Jan; 42(1):78-84. PubMed ID: 23913779
[TBL] [Abstract][Full Text] [Related]
28. Cribriform morular variant of papillary thyroid carcinoma: clinical and cytomorphological features on fine-needle aspiration.
Boonyaarunnate T; Olson MT; Bishop JA; Yang GC; Ali SZ
Acta Cytol; 2013; 57(2):127-33. PubMed ID: 23406819
[TBL] [Abstract][Full Text] [Related]
29. Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: a case report.
Cameselle-Teijeiro J; Abdulkader I; Barreiro-Morandeira F; Ruiz-Ponte C; Reyes-Santías R; Chavez E; Sobrinho-Simões M
Int J Surg Pathol; 2006 Jan; 14(1):79-84. PubMed ID: 16501842
[TBL] [Abstract][Full Text] [Related]
30. BRAF mutational analysis in papillary carcinomas with mixed follicular and papillary growth patterns.
Jakubowski M; Hunt JL
Am J Surg Pathol; 2009 Nov; 33(11):1590-3. PubMed ID: 19738460
[TBL] [Abstract][Full Text] [Related]
31. Sulindac reverses aberrant expression and localization of beta-catenin in papillary thyroid cancer cells with the BRAFV600E mutation.
Cho NL; Lin CI; Whang EE; Carothers AM; Moore FD; Ruan DT
Thyroid; 2010 Jun; 20(6):615-22. PubMed ID: 20470206
[TBL] [Abstract][Full Text] [Related]
32. Cytologic characteristics and β-catenin immunocytochemistry on smear slide of cribriform-morular variant of papillary thyroid carcinoma.
Koo JS; Jung W; Hong SW
Acta Cytol; 2011; 55(1):13-8. PubMed ID: 21135516
[TBL] [Abstract][Full Text] [Related]
33. Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.
Nakazawa T; Celestino R; Machado JC; Cameselle-Teijeiro JM; Vinagre J; Eloy C; Benserai F; Lameche S; Soares P; Sobrinho-Simões M
Int J Surg Pathol; 2013 Aug; 21(4):379-89. PubMed ID: 23349472
[TBL] [Abstract][Full Text] [Related]
34. [An investigation of BRAF mutation in papillary thyroid carcinoma and its clinical value].
Gong RX; Zhou Y; Luo SH; Zhang L; Zhou B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):310-3. PubMed ID: 19504446
[TBL] [Abstract][Full Text] [Related]
35. Cribriform-morular variant of papillary thyroid carcinoma--cytological and immunocytochemical findings of 18 cases.
Hirokawa M; Maekawa M; Kuma S; Miyauchi A
Diagn Cytopathol; 2010 Dec; 38(12):890-6. PubMed ID: 20091902
[TBL] [Abstract][Full Text] [Related]
36. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.
Kim SK; Kim DL; Han HS; Kim WS; Kim SJ; Moon WJ; Oh SY; Hwang TS
Diagn Mol Pathol; 2008 Jun; 17(2):118-25. PubMed ID: 18382358
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic dilemmas of hyalinizing trabecular tumours on fine needle aspiration cytology: a study of seven cases with BRAF mutation analysis.
Kim T; Oh YL; Kim KM; Shin JH
Cytopathology; 2011 Dec; 22(6):407-13. PubMed ID: 21733000
[TBL] [Abstract][Full Text] [Related]
38. [Clinical role of BRAF V600E mutation testing in thyroid nodules].
Wan H; Zhang B; Wang Y; Xiao T; Guo H; Liu W; Yan D; Xu Z; Tang P
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jun; 49(6):468-72. PubMed ID: 25241863
[TBL] [Abstract][Full Text] [Related]
39. Morules in cribriform-morular variant of papillary thyroid carcinoma: Immunohistochemical characteristics and distinction from squamous metaplasia.
Hirokawa M; Kuma S; Miyauchi A; Qian ZR; Nakasono M; Sano T; Kakudo K
APMIS; 2004; 112(4-5):275-82. PubMed ID: 15233643
[TBL] [Abstract][Full Text] [Related]
40. Fine-needle aspiration of metastatic papillary thyroid carcinoma found in the liver.
VandenBussche CJ; Gocke CD; Li QK
Diagn Cytopathol; 2013 May; 41(5):418-24. PubMed ID: 22362717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
